Non-genomic vasorelaxant effects of 17Β-estradiol and progesterone in rat aorta are mediated by L-type Ca 2+ current inhibition

Acta Pharmacologica Sinica

Volumn 33, Issue 5, 2012, Pages 615-624

  Cairro, Elisa ^a   Alvarez, Ezequiel ^a   Carvas, Joo Miguel ^a   Santos Silva, Antonio Jose ^a   Verde, Ignacio ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

17 estradiol; A7r5 cel; Ca 2+ channel; Female sex hormone; K + channel; Non genomic action; Progesterone; Rat aorta artery ring; Vasorelaxant effect

Indexed keywords

CALCIUM CHANNEL L TYPE; ESTRADIOL; FULVESTRANT; GLIBENCLAMIDE; MIFEPRISTONE; PROGESTERONE; TETRYLAMMONIUM;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; POTASSIUM CURRENT; RAT; VASODILATATION; VOLTAGE CLAMP;

ANIMALS; AORTA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR BETA; HORMONE ANTAGONISTS; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROGESTERONE; RATS; RATS, WISTAR; RECEPTORS, PROGESTERONE; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 84860745045     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.4     Document Type: Article

References (49)

1. Miller VM. Sex-based differences in vascular function. Womens Health (Lond Engl) 2010; 6 : 737-52.
2. Masood DE, Roach EC, Beauregard KG, Khalil RA. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab 2010; 11: 693-714.
3. Davis SR, Panjari M, Stanczyk FZ. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011; 96: 1642-53.
4. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003; 24 : 313-40. (Pubitemid 36724373)
5. Kim JK, Levin ER. Estrogen signaling in the cardiovascular system. Nucl Recept Signal 2006; 4: e013.
6. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004; 286: R233-49. (Pubitemid 38140366)
7. Edwards DP. Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 2005; 67: 335-76. (Pubitemid 40409510)
8. Santos RL, Marin EB, Goncalves WL, Bissoli NS, Abreu GR, Moyses MR. Sex differences in the coronary vasodilation induced by 17 beta-oestradiol in the isolated perfused heart from spontaneously hypertensive rats. Acta Physiol (Oxf) 2010; 200: 203-10.
9. Lekontseva O, Chakrabarti S, Jiang Y, Cheung CC, Davidge ST. Role of neuronal nitric oxide synthase in estrogen-induced relaxation in rat resistance arteries. J Pharmacol Exp Ther 2011; 339: 367-75.
10. Crews JK, Khalil RA. Antagonistic effects of 17-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 1999; 19: 1034-40. (Pubitemid 29177353)
11. Barbagallo M, Dominguez LJ, Licata G, Shan J, Bing L, Karpinski E, et al. Vascular effects of progesterone : role of cellular calcium regulation. Hypertension 2001; 37: 142-7. (Pubitemid 32064252)
12. Unemoto T, Honda H, Kogo H. Differences in the mechanisms for relaxation of aorta induced by 17beta-estradiol or progesterone between normotensive and hypertensive rats. Eur J Pharmacol 2003; 472: 119-26. (Pubitemid 36830997)
13. Castillo C, Ceballos G, Rodriguez D, Villanueva C, Medina R, Lopez J, et al. Effects of estradiol on phenylephrine contractility associated with intracellular calcium release in rat aorta. Am J Physiol Cell Physiol 2006; 291: C1388-94. (Pubitemid 44878610)
14. Barton M, Cremer J, Mugge A. 17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries. Eur J Pharmacol 1998; 362: 73-6. (Pubitemid 29000999)
15. Salom JB, Burguete MC, Perez-Asensio FJ, Torregrosa G, Alborch E. Relaxant effects of 17-beta-estradiol in cerebral arteries through Ca2+ entry inhibition. J Cereb Blood Flow Metab 2001; 21: 422-9. (Pubitemid 32298889)
16. Belfor t MA, Saade GR, Suresh M, Vedernikov YP. Effects of estradiol-17 beta and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women. Am J Obstet Gynecol 1996; 174: 246-53. (Pubitemid 26037718)
17. Kocic I, Szczepanska R, Wapniarska I. Estrogen-induced relaxation of the rat tail artery is attenuated in rats with pulmonary hypertension. Pharmacol Rep 2010; 62: 95-9.
18. Keung W, Man RY. Circulating sex hormones modulate vascular contractions and acute response to 17beta-estradiol in rat mesenteric arteries. Pharmacology 2011; 88: 55-64.
19. Keung W, Chan ML, Ho EY, Vanhoutte PM, Man RY. Non-genomic activation of adenylyl cyclase and protein kinase G by 17beta-estradiol in vascular smooth muscle of the rat superior mesenteric artery. Pharmacol Res 2011; 64: 509-16.
20. McFadzean I, Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol 2002; 135: 1-13. (Pubitemid 34103011)
21. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, Kurachi Y. 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol 1995; 294: 625-35. (Pubitemid 26016768)
22. Okabe K, Inoue Y, Soeda H. Estradiol inhibits Ca2+ and K+ channels in smooth muscle cells from pregnant rat myometrium. Eur J Pharmacol 1999; 376: 101-8. (Pubitemid 29320175)
23. Hill BJ, Gebre S, Schlicker B, Jordan R, Necessary S. Nongenomic inhibition of coronary constriction by 17ss-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol. Can J Physiol Pharmacol 2010; 88: 147-52.
24. Li HF, Zheng TZ, Li W, Qu SY, Zhang CL. Effect of progesterone on the contractile response of isolated pulmonary artery in rabbits. Can J Physiol Pharmacol 2001; 79: 545-50. (Pubitemid 32745050)
25. Zhang M, Benishin CG, Pang PK. Rapid inhibition of the contraction of rat tail artery by progesterone is mediated by inhibition of calcium currents. J Pharm Pharmacol 2002; 54: 1667-74. (Pubitemid 36018816)
26. Zhang F, Ram JL, Standley PR, Sowers JR. 17beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 1994; 266: C975-80.
27. Ruehlmann DO, Steinert JR, Valverde MA, Jacob R, Mann GE. Environmental estrogenic pollutants induce acute vascular relaxation by inhibiting L-type Ca2+ channels in smooth muscle cells. FASEB J 1998; 12: 613-9. (Pubitemid 28183520)
28. De Wet H, Allen M, Holmes C, Stobbart M, Lippiat JD, Callaghan R. Modulation of the BK channel by estrogens: examination at single channel level. Mol Membr Biol 2006; 23: 420-9. (Pubitemid 44630025)
29. Tsang SY, Yao X, Chan HY, Wong CM, Chen ZY, Au CL, et al. Contribution of K+ channels to relaxation induced by 17beta-estradiol but not by progesterone in isolated rat mesenteric artery rings. J Cardiovasc Pharmacol 2003; 41: 4-13. (Pubitemid 36015050)
30. White RE, Han G, Maunz M, Dimitropoulou C, El-Mowafy AM, Barlow RS, et al. Endothelium-independent effect of estrogen on Ca2+-activated K+ channels in human coronary artery smooth muscle cells. Cardiovasc Res 2002; 53: 650-61. (Pubitemid 34175258)
31. Han G, Yu X, Lu L, Li S, Ma H, Zhu S, et al. Estrogen receptor alpha mediates acute potassium channel stimulation in human coronary artery smooth muscle cells. J Pharmacol Exp Ther 2006; 316: 1025-30. (Pubitemid 43345274)
32. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005; 46: 249-54. (Pubitemid 41099147)
33. Qiao X, McConnell KR, Khalil RA. Sex steroids and vascular responses in hypertension and aging. Gend Med 2008; 5 Suppl A: S46-S64. (Pubitemid 351455231)
34. Korovkina VP, Brainard AM, Ismail P, Schmidt TJ, England SK. Estradiol binding to maxi-K channels induces their down-regulation via proteasomal degradation. J Biol Chem 2004; 279: 1217-23. (Pubitemid 38082645)
35. Perusquia M, Hernandez R, Morales MA, Campos MG, Villalon CM. Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen Pharmacol 1996; 27: 181-5. (Pubitemid 26076862)
36. Rodriguez J, Garcia de Boto MJ, Hidalgo A. Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci 1996; 58 : 607-15. (Pubitemid 26049946)
37. Alvarez E, Cairrao E, Morgado M, Morais C, Verde I. Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition. Adv Pharmacol Sci 2010; doi:10.1155/2010/534184.
38. Glusa E, Graser T, Wagner S, Oettel M. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 1997; 28: 181-91. (Pubitemid 28085904)
39. Salom JB, Burguete MC, Perez-Asensio FJ, Centeno JM, Torregrosa G, Alborch E. Acute relaxant effects of 17-beta-estradiol through nongenomic mechanisms in rabbit carotid artery. Steroids 2002; 67: 339-46. (Pubitemid 34214744)
40. Geary GG, Krause DN, Duckles SP. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol 1998; 275: H292-300.
41. Omar HA, Ramirez R, Gibson M. Properties of a progesterone-induced relaxation in human placental arteries and veins. J Clin Endocrinol Metab 1995; 80: 370-3.
42. Iliescu R, Campos LA, Schlegel WP, Morano I, Baltatu O, Bader M. Androgen receptor independent cardiovascular action of the antiandrogen flutamide. J Mol Med 2003; 81: 420-7. (Pubitemid 36900537)
43. Ba ZF, Wang P, Kuebler JF, Rue LW, 3rd, Bland KI, Chaudry IH. Flutamide induces relaxation in large and small blood vessels. Arch Surg 2002; 137: 1180-6. (Pubitemid 35155259)
44. T russ M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993; 14 : 459-79. (Pubitemid 23238927)
45. Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003; 148: 281-92. (Pubitemid 36410713)
46. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR. In vitro effects of progesterone and progestins on vascular cells. Steroids 2003; 68: 831-6. (Pubitemid 37532407)
47. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008; 70: 165-90. (Pubitemid 351738176)
48. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007; 148: 3236-45. (Pubitemid 46997004)
49. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009; 104: 288-91.